71 2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices “We are pleased to partner with BD to provide valuable training for technicians at 21 liquid culture drug susceptibility test TB laboratories in Indonesia. We are confident that as a result of our partnership, these laboratories will be better able to adjust their testing and help roll out a new patient-friendly oral treatment that will benefit tens of thousands of people across the country in the years to come.” USAID “The training material fits the purpose and needs as it has been discussed extensively to align with Substansi TB (NTP-MOH) and BBLK Surabaya (CDST NRL TB).” NTP of the MOH of Indonesia Indonesia In FY 2019, BD signed a memorandum of understanding with USAID to expand the STRIDES program to support the National TB Program (NTP) of the MOH of Indonesia, a country that has the second highest global TB burden after India and where one of the goals is building capacity for drug-resistant TB testing in the country. In June 2021, BD partnered with Project HOPE to conduct a four-day online training session for 69 lab personnel across 21 public sector laboratories on LC and DST. To understand the impact of the online training, in December 2021, an independent assessment was conducted among participants and showed significant knowledge retention with an average correct response rate of 87 percent. In addition, 88 percent of the respondents agreed that the training content met their expectations, with 98 percent mentioning that the training benefited them in their day-to-day operations at the lab. The STRIDES partnership has showcased BD’s commitment to be a solution provider, and to support high-burden countries—India and Indonesia—in achieving their national targets to eliminate TB. Evaluation of laboratory and e-learning at the BLK in Semarang, Indonesia, with Dr. Retno (MOH), and the National Reference Laboratory (NRL). STRIDES monitoring and evaluation e-learning report to the MOH and online discussion with the TB Lab Network Workshop on lab strengthening capacity with NTP and the TB Lab Network